Biofeedback-assisted relaxation therapy in neurocardiogenic syncope: a pilot study.

This controlled pilot study explored the effects of biofeedback assisted relaxation (BFRT) in neurocardiogenic syncope. Twenty-two patients who completed a 2-week pretest, were randomized to either treatment or wait list control, followed by a 2-week posttreatment/control period. Treatment comprised electromyograph and thermal biofeedback, autogenic and progressive relaxation, and symptom-specific recommendations. Significant differences (p < .05) between groups were observed in the headache index and loss of consciousness, favoring the BFRT group. Both groups decreased state anxiety and depression. The Millon Behavioral Health Inventory was used to assess patients' coping style and adjustment to illness. The majority of the adult participants evidenced illness overreaction, preoccupation with illness, depressive feelings, and tendencies to nonadherence to therapy. BFRT is of potential benefit to patients with neurocardiogenic syncope, but further study is necessary to define the influence of coping style on outcome.

Biofeedback-assisted relaxation in migraine headache: relationship to cerebral blood flow velocity in the middle cerebral artery.

OBJECTIVE: To determine if migraineurs with aura respond differently to biofeedback/relaxation than those without aura and, if so, whether the variability in outcome can be explained by blood flow velocity. Background.-The relationship between cerebral blood flow velocity and treatment response to biofeedback/relaxation in migraine with and without aura is uncertain. METHOD: Twenty migraineurs underwent 12 sessions of biofeedback/relaxation therapy, while 20 controls simply were told to relax on their own. Cerebral blood flow velocity was measured bilaterally in the middle cerebral artery with transcranial Doppler. RESULTS: The biofeedback group showed significant (P <.05) reductions in pain, depression, and anxiety compared to the control group. Patients with and without aura did equally well. There were significant (P <.05) left to right blood flow velocity differences only in the migraine with aura group. Maximum blood flow velocities were significantly higher (P <.05) in the migraine with aura group than in the cohort without aura. There was an inverse correlation between indicators of anxiety and blood flow velocity, perhaps related to hyperventilation-induced constriction in the small vessels distal to the middle cerebral artery. CONCLUSION: The positive treatment response to biofeedback/relaxation in migraine headache is not related to presence of aura, nor to changes in blood flow velocity, but may be associated with reduction in anxiety and depression.